Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE We used the modified ISTH score for DIC, which is based on platelet count, fibrinogen concentration, and prothrombin time (PT) differences. 29065752 2019
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Abbreviations: AML: acute myeloid leukemia; APL: acute promyelocytic leukemia; WBC: white blood cell; RBC: red blood cell; Hb: hemoglobin; PT: prothrombin time; TT: thrombin time; APTT: activated partial thromboplastin time; TP: total protein; ALB: albumin; AST: aspartate transaminase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; ATRA: all-trans retinoic acid; ICH: intracranial hemorrhage; DIC: disseminated intravascular coagulation. 30453810 2019
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model. 31180918 2019
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Prothrombin time (PT) with international normalized ratio (INR) was estimated at similar intervals to detect venom-induced consumption coagulopathy. 30918965 2019
Disseminated Intravascular Coagulation
0.600 GeneticVariation disease BEFREE In Swiss albino mice, intraperitoneal injection of PAF causes sudden death with oxidative stress and disseminated intravascular coagulation (DIC), characterized by prolonged prothrombin time, thrombocytopenia, reduced fibrinogen content, and increased levels of fibrinogen degradation products. 31442556 2019
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Potential factors influencing adverse maternal outcome were male fetus (p = 0.04), postpartum diagnosis of AFLP (p < 0.01), intrauterine fetal death (p = 0.04), disseminated intravascular coagulation (p < 0.01), prothrombin time (p < 0.01) and activated partial thromboplastin time (p = 0.04). 29297090 2018
Disseminated Intravascular Coagulation
0.600 GeneticVariation disease BEFREE The disseminated intravascular coagulation (DIC) score, which is based on readily available and relatively inexpensive coagulation parameters, including platelet count, fibrin-related markers, prothrombin time and fibrinogen, has not been reported regarding PVT development in cirrhotic patients to date. 29178991 2018
Disseminated Intravascular Coagulation
0.600 GeneticVariation disease BEFREE Secondary outcomes included platelet count, disseminated intravascular coagulation (DIC), and prothrombin time (PT). 30064685 2018
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Laboratory measurement of prothrombin fragment 1.2, a byproduct of prothrombin conversion to thrombin, proved to be a useful way to monitor this patient's DIC over time. 30461646 2018
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Moreover, treatment with rTM significantly improved DIC score, fibrinogen, fibrin/fibrinogen degradation product (FDP), and prothrombin time (PT) ratio. 30383650 2018
Disseminated Intravascular Coagulation
0.600 AlteredExpression disease BEFREE From medical records, we collected information about the following coagulation and fibrinolytic factors at hospital admission: platelet count; prothrombin time; activated partial thromboplastin time; plasma levels of fibrinogen, D-dimer, fibrin/fibrinogen degradation products (FDP), and antithrombin; and calculated DIC score. 27940211 2017
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE We examined whether a dual short-acting thrombin (factor II) and factor X (FX)a inhibitor (SATI) ameliorates sepsis-induced disseminated intravascular coagulation (DIC) and is organ-protective. 28288667 2017
Disseminated Intravascular Coagulation
0.600 Biomarker disease RGD Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model. 23737601 2013
Disseminated Intravascular Coagulation
0.600 Biomarker disease RGD Exogenous normal lymph alleviating kidney injury by improving coagulation function in disseminated intravascular coagulation rats. 22229668 2012
Disseminated Intravascular Coagulation
0.600 AlteredExpression disease BEFREE DIC, defined as platelet counts below 100 G L(-1), increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC. 17697137 2007
Disseminated Intravascular Coagulation
0.600 Biomarker disease BEFREE Group 1 and 2 animals developed features of disseminated intravascular coagulation (DIC), with reductions of fibrinogen and platelets and increases of prothrombin time, partial thromboplastin time, and fibrin split products.Graft survival was for 6-13 days. 11740383 2001
Disseminated Intravascular Coagulation
0.600 Biomarker disease CTD_human Hirudin in disseminated intravascular coagulation. 1894189 1991